Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma

Fertility and Sterility

Volumn 90, Issue 3, 2008, Pages 789-797

  Salih, Sana M ^a   Salama, Salama A ^a   Fadl, Amin A ^b   Nagamani, Manubai ^a   Al Hendy, Ayman ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Tuskegee University College of Veterinary Medicine Nursing and Allied Health   (United States)

Author keywords

2 methoxy estrogen; catechol estrogen; Catechol O methyl transferase; human endometrial stroma

Indexed keywords

2 METHOXY ESTROGEN; CATECHOL METHYLTRANSFERASE; DNA; ESTROGEN; ISOPROTEIN; LUCIFERASE; MESSENGER RNA; PROGESTERONE; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM; ENZYME REGULATION; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; STROMA CELL; TRANSACTIVATION; UPREGULATION; WESTERN BLOTTING;

ADULT; CATECHOL O-METHYLTRANSFERASE; CELLS, CULTURED; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; STROMAL CELLS;

EID: 51449088920     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.042     Document Type: Article

References (39)

1. Spicer L.J., and Hammond J.M. Regulation of ovarian function by catecholestrogens: current concepts. J Steriod Biochem 33 (1989) 489-501
2. Merriam G., MacLusky N.J., Pickard M., and Naftolin F. Comparative properties of the catechol extrogens. I, Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors. Steroids 369 (1980) 1-11
3. Bradlow L.H. 2-Hydroxyesterone: the "good" estrogen. J Endocrinol 150 (1996) S259-S265
4. MacLusky N., Barena E., Clark C., and Naftolin F. Catheol estrogens and estrogen receptors. In: Mirriam G.R., and Lipsett M. (Eds). Catechol estrogens (1983), Raven Press, New York 151-165
5. Mannisto P.T., and Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51 (1999) 593-628
6. Fotsis T., Zhang Y., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P., et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368 (1994) 237-239
7. Klauber N., Parangi S., Flynn E., Hamel E., and D'Amato R.J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57 (1997) 81-86
8. D'Amato R.J., Lin C.M., Flynn E., Folkman J., and Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91 (1994) 3964-3968
9. Brown J.W., Kesler C.T., Neary T., and Fishman L.M. Effects of androgens and estrogens and catechol and methoxy-estrogen derivatives on mitogen-activated protein kinase (ERK(1,2)) activity in SW-13 human adrenal carcinoma cells. Horm Metab Res 33 (2001) 127-130
10. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (2000), Cold Springs Harbor Laboratory Press, New York
11. Al-Hendy A., and Salama S.A. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 13 (2006) 136-144
12. Ausubel F.M., Brent R., and Kingston R.E. Current protocols in molecular biology (1987), Greene Publishing Associates and Wiley-Interscience, New York
13. Salama S.A., Ho S.L., Wang H.Q., Tenhunen J., Tilgmann C., and Al Hendy A. Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas. Fertil Steril 86 (2006) 259-262
14. Taylor H.S., Arici A., Olive D., and Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 101 (1998) 1379-1384
15. Al-Hendy A., Lee E.J., Wang H.Q., and Copland J.A. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol 191 (2004) 1621-1631
16. von Wolff M., Thaler C.J., Strowitzki T., Broome J., Stolz W., and Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 6 (2000) 627-634
17. Huang J.C., Liu D.Y., and Dawood M.Y. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol. Mol Hum Reprod 4 (1998) 603-607
18. Tabibzadeh S., Zupi E., Babaknia A., Liu R., Marconi D., and Romanini C. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum Reprod 10 (1995) 277-286
19. Jabbour H.N., Kelly R.W., Fraser H.M., and Critchley H.O. Endocrine regulation of menstruation. Endocr Rev 27 (2006) 17-46
20. Weisz J., Fritz-Wolz G., Clawson G.A., Benedict C.M., Abendroth C., and Creveling C.R. Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer. Carcinogenesis 19 (1998) 1307-1312
21. Jiang H., Xie T., Ramsden D.B., and Ho S.L. Human catechol-O-methyltransferase downregulation by estradiol. Neuropharmacology 45 (2003) 1011-1018
22. Xie T., Ho S.L., and Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56 (1999) 31-38
23. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G., et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55 (2000) 163-193
24. Villavicencio A., Bacallao K., Avellaira C., Gabler F., Fuentes A., and Vega M. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia. Gynecol Oncol 103 (2006) 307-314
25. Nephew K.P., Osborne E., Lubet R.A., Grubbs C.J., and Khan S.A. Effects of oral administration of tamoxifen, toremifene, dehydroepiandrosterone, and vorozole on uterine histomorphology in the rat. Proc Soc Exp Biol Med 223 (2000) 288-294
26. Gelbke H.P., Ball P., and Knuppen R. 2-Hydroxyoestrogens. Chemistry, biogenesis, metabolism and physiological significance. Adv Steroid Biochem Pharmacol 6 (1977) 81-154
27. Zacharia L.C., Gogos J.A., Karayiorgou M., Jackson E.K., Gillespie D.G., Barchiesi F., et al. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice. Circulation 108 (2003) 2974-2978
28. Barnea E.R., and Avigdor S. Coordinated induction of estrogen hydroxylase and catechol-O-methyl transferase by xenobiotics in first trimester human placental explants. J Steroid Biochem 35 (1990) 327-331
29. Punyadeera C., Thijssen V.L., Tchaikovski S., Kamps R., Delvoux B., Dunselman G.A., et al. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod 12 (2006) 367-375
30. Ma W., Tan J., Matsumoto H., Robert B., Abrahamson D.R., Das S.K., et al. Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 15 (2001) 1983-1992
31. Wang H., and Dey S.K. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7 (2006) 185-199
32. Chakraborty C., Davis D.L., and Dey S.K. The O-methylation of catechol oestrogens by pig conceptuses and endometrium during the peri-implantation period. J Endocrinol 127 (1990) 77-84
33. Paria B.C., Lim H., Wang X.N., Liehr J., Das S.K., and Dey S.K. Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 139 (1998) 5235-5246
34. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95 (1998) 9991-9996
35. Carson D.D., Bagchi I., Dey S.K., Enders A.C., Fazleabas A.T., Lessey B.A., et al. Embryo implantation. Dev Biol 223 (2000) 217-237
36. Red-Horse K., Zhou Y., Genbacev O., Prakobphol A., Foulk R., McMaster M., et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114 (2004) 744-754
37. Shang W., Konidari I., and Schomberg D.W. 2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod 65 (2001) 622-627
38. Klauber N., Rohan R.M., Flynn E., and D'Amato R.J. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 3 (1997) 443-446
39. Zhu B.T., and Liehr J.G. Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: implications for the mechanism of estrogen-induced carcinogenesis. Arch Biochem Biophys 304 (1993) 248-256